OBJECTIVES To review the current research and published literature regarding the development of rat models of Myocardial Infarction (MI) and give a comprehensive evaluation on them.
METHODS A review of the current and relevant papers and research information via a search of several large databases of medical from January 1980 to present.
RESULTS
Comparing with other animals like pig or monkey, rats have advantages on feeding and related cost. This model of MI has been the dominant choose of the experimental study by taking up 70% or even higher proportion in this field. With the progressing of science and technology, some new methods in rat MI models such as balloon occlusion and gene knockout are spring up in these years. However, the seemingly old method -coronary artery ligation is still be the first choice of most researchers. Isopropyl adrenaline induced model is also usually been adopted too. More recent efforts have been aimed at making those mature and classic methods more perfect.
CONCLUSIONS Rat model of MI can be relatively quickly made now by ligation of left anterior descending branch of the coronary artery, and its mortality has decreased effectively based on existing researches. This model will continue to be a priority for researchers in a long period of time. effect. And rosuvastatin itself also increased the TM activity. However nicotine was no effect on the above indices of TM.
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CONCLUSIONS Tar may inhibit the activity of TM though decreasing the binding probability between TM and thrombin. Rosuvastatin may prevent tar-induced the decreasing of TM activity by increasing TM expression, reversing the binding probability between TM and thrombin and enhancing the binding force between TM and thrombin. However nicotine was no effect on the activity of TM. This study provided a new approach and new evidence for studying the mechanism of thrombosis triggered by cigarette smoking and the anticoagulation mechanism for rosuvastatin. OBJECTIVES Vascular smooth muscle cell (VSMC) phenotype transformation is an important phenomenon of vessel neointima in lesion progression. CD137 can accelerate the plaque formation, but the detailed mechanisms are unclear. Thus, we investigated the effect of CD137 signaling on VSMC phenotype transformation as well as the potential underlying mechanism.
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METHODS Agonist-CD137 antibody and anti-CD137 antibody were used to activate or block CD137 axis respectively in ApoE -/-mice or VSMC. The content of miR-145, NFATc1 and phenotype marker was measured by RT-PCR and western blot. Immunofluorescence was used to observe the distribution of NFATc1 or nuclear translocation. VSMCs were transfected with miR-145a-5p mimics or inhibitors by Lipofectamine. Eukaryotic expression vector and luciferase vector were constructed and co-transfected to the 293T with mimics or inhibitors to measure the protein level and fluorescence intensity respectively. Stable VSMC cell line which knock-down NFATc1 or overexpress miR-145 and control were built by lenti-virus. CCK-8 assay and transwell assay were performed to detect the proliferation and migration of cell. miR-145 agomir and agonist CD137 antibody were used in ApoE -/-mice and Immunohistochemistry or Masson's trichrome assay were performed to observe the plaque stability.
RESULTS miR-145a-5p expression was downregulate (0.28AE0.06 VS 1.00AE0.00, 0.28AE0.06 VS 0.67AE0.13, p<0.05), whereas expression of nuclear factor of activated T-cells c1 (NFATc1) was significantly upregulated (2.21AE0.21 VS 1.47AE0.13, p<0.05). Phenotype markers such as SM-MHC, ɑ-SMA and vimentin were also altered in vivo or in vitro upon treatment with agonistic CD137 antibody (0.28AE0.03 VS 0.540AE0.12, 0.18AE0.04 VS 0.66AE0.08, 0.34AE0.05 VS 2.42AE0.23, p<0.05). Overexpression of NFATc1 by plasmid transfection demonstrated that NFATc1 independently contributed to phenotype modulation in VSMC. Otherwise, dual-luciferase report assay and mimic/ inhibitor transfection demonstrated that NFATc1 was the target gene of miR-145 (0.41AE0.05 1.00AE0.00, 0.36AE0.07 VS 1.00AE0.00, p<0.05). Inhibition of miR-145a-5p upregulated overexpression of miR-145a-5p but downregulated NFATc1 in vitro. Both overexpression of miR-145 and knockdown NFATc1 suppressed the proliferation and migration of VSMC and inhibited the phenotype transformation of VSMC induced by CD137. Up-regulating miR-145 through agomir in Apoe -/-mice significantly reduced atherosclerotic lesion areas induced by CD137 in multi ways.
CONCLUSIONS Results indicate that CD137/NFATc1 pathway plays an important role in regulating VSMC phenotype transformation and miR-145 directly regulates NFATc1 expression in CD137 signaling.
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Effect of CD137 Signaling on the Expression of Nuclear Factor of Activated T-Cells, Cytoplasmic 1(NFATc1) in Mice VSMCs Through TRAF6/NF-kB Pathway
